SG11202104952PA - Gdf15 analogs and methods for use in decreasing body weight and/or reducing food intake - Google Patents

Gdf15 analogs and methods for use in decreasing body weight and/or reducing food intake

Info

Publication number
SG11202104952PA
SG11202104952PA SG11202104952PA SG11202104952PA SG11202104952PA SG 11202104952P A SG11202104952P A SG 11202104952PA SG 11202104952P A SG11202104952P A SG 11202104952PA SG 11202104952P A SG11202104952P A SG 11202104952PA SG 11202104952P A SG11202104952P A SG 11202104952PA
Authority
SG
Singapore
Prior art keywords
methods
body weight
food intake
reducing food
decreasing body
Prior art date
Application number
SG11202104952PA
Other languages
English (en)
Inventor
Holly Kimko
Robert Hermann
Elisa Fabbrini
Vedrana Stojanovic-Susulic
Paul Rothenberg
Songmao Zheng
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SG11202104952PA publication Critical patent/SG11202104952PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG11202104952PA 2018-11-20 2019-11-19 Gdf15 analogs and methods for use in decreasing body weight and/or reducing food intake SG11202104952PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862769675P 2018-11-20 2018-11-20
PCT/IB2019/059945 WO2020104948A1 (en) 2018-11-20 2019-11-19 Gdf15 analogs and methods for use in decreasing body weight and/or reducing food intake

Publications (1)

Publication Number Publication Date
SG11202104952PA true SG11202104952PA (en) 2021-06-29

Family

ID=70773869

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202104952PA SG11202104952PA (en) 2018-11-20 2019-11-19 Gdf15 analogs and methods for use in decreasing body weight and/or reducing food intake

Country Status (15)

Country Link
US (1) US20220315633A1 (ja)
EP (1) EP3883960A4 (ja)
JP (1) JP2022513098A (ja)
KR (1) KR20210094584A (ja)
CN (1) CN113474363A (ja)
AU (1) AU2019383019A1 (ja)
BR (1) BR112021009225A2 (ja)
CA (1) CA3120236A1 (ja)
EA (1) EA202191424A1 (ja)
IL (1) IL283189A (ja)
JO (1) JOP20210111A1 (ja)
MX (1) MX2021005908A (ja)
PH (1) PH12021551119A1 (ja)
SG (1) SG11202104952PA (ja)
WO (1) WO2020104948A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230210950A1 (en) 2019-10-04 2023-07-06 Amgen Inc. Use of gdf15 for treating cardiometabolic syndrome and other conditions
WO2023154953A1 (en) 2022-02-14 2023-08-17 Ngm Biopharmaceuticals, Inc. Gdf15 polypeptides for treating and preventing autoimmune diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9131966B2 (en) * 2013-03-11 2015-09-15 DePuy Synthes Products, Inc. Vertebral manipulation assembly
EP3157947A1 (en) * 2014-06-23 2017-04-26 Novartis AG Hsa-gdf-15 fusion polypeptide and use thereof
EP3393494A1 (en) * 2015-12-22 2018-10-31 Novartis Ag Methods of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15)
US10336812B2 (en) * 2016-05-10 2019-07-02 Janssen Biotech, Inc. GDF15 fusion proteins and uses thereof
CA3116983A1 (en) * 2018-10-22 2020-04-30 Janssen Pharmaceutica Nv Glucagon like peptide 1 (glp1)-growth differentiation factor 15 (gdf15) fusion proteins and uses thereof

Also Published As

Publication number Publication date
WO2020104948A1 (en) 2020-05-28
CN113474363A (zh) 2021-10-01
IL283189A (en) 2021-06-30
JP2022513098A (ja) 2022-02-07
KR20210094584A (ko) 2021-07-29
PH12021551119A1 (en) 2021-11-22
US20220315633A1 (en) 2022-10-06
CA3120236A1 (en) 2020-05-28
EP3883960A4 (en) 2022-11-09
BR112021009225A2 (pt) 2021-10-05
JOP20210111A1 (ar) 2023-01-30
EA202191424A1 (ru) 2021-08-24
AU2019383019A1 (en) 2021-06-03
MX2021005908A (es) 2021-09-08
EP3883960A1 (en) 2021-09-29

Similar Documents

Publication Publication Date Title
EP3445355C0 (en) BETA-HYDROXYBUTYRATE FOR NON-THERAPEUTIC USE IN CONTROLLING WEIGHT LOSS AND KETOSIS
EP3592639C0 (en) HUMAN-POWERED HYPERFOIL VEHICLE AND METHOD OF USE
IL283189A (en) GDF15 analogs and methods for use in reducing body weight and/or reducing food intake
EP3688021A4 (en) Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders
GB2582521B (en) Preserved tissue products and related methods
PL3187178T3 (pl) Kompozycja oraz leki do zmniejszania ilości zlokalizowanej tkanki tłuszczowej i masy ciała oraz ich zastosowanie
PL3164144T3 (pl) Kompozycja Lactobacillus umożliwiająca promowanie wzrostu u młodych osobników ludzi i zwierząt w przypadku nieprawidłowego stanu odżywienia
IL276814A (en) Indazole-3-carboxamides converted in 5-heteroaryl and their preparation and use
PT3773092T (pt) Posicionamento controlado no processador de alimentos
IL281569A (en) Use of tradifitant in motion sickness
EP3468670C0 (en) PREDETERMINED DIET FOR WEIGHT LOSS INDUCTION AND WEIGHT GAIN PREVENTION
PL3675879T3 (pl) Cerebrolizyna do zastosowania w leczeniu cadasil
EP3518951C0 (en) COMPOSITIONS FOR USE IN THE TREATMENT OF OSTEOPOROSIS AND Fractures
GB2574309B (en) Improvements in or relating to prosthetic limbs
EP3879973C0 (en) ARRANGEMENT AND SYSTEM FOR MEASURING BODY TEMPERATURE OF POULTRY
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
PT3408287T (pt) Gdf15 em glaucoma e respetivos métodos de utilização
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
PT3937949T (pt) Fitoecdisonas e seus derivados para utilização no tratamento da alteração da função respiratória
ZA201804198B (en) Composition of olivetol and method of use reduce or inhibit the effects of tetrahydrocannabinol in the human body
EP3651770C0 (en) THEACRINE SUPPLEMENT AND METHOD OF USE THEREOF IN A SYNERGIC COMBINATION WITH CAFFEINE
IL258932B (en) Preparations and their use in food preservation
SG10201607758TA (en) Mattress with adjustable hardness and comfort levels
GB201906555D0 (en) Improvements in or relating to storage and conveying apparatuses
PL3657964T3 (pl) Suplementy diety do zastosowania w profilaktyce i leczeniu migreny